Inheritance

SandRidge Mississippian Trust I Announces Update Regarding Future Distribution of Net Asset Sale Proceeds

Tuesday, July 27, 2021 - 9:15pm

Instead, the Trustee is withholding such net proceeds as part of its cash reserve.

Key Points: 
  • Instead, the Trustee is withholding such net proceeds as part of its cash reserve.
  • After the securities litigation has been resolved, the Trustee will distribute any remaining cash reserves following the payment of the Trusts estimated remaining expenses and liabilities.
  • Such a reserve could reduce or eliminate the amount of, or delay the timing of payment of, sale proceeds that may be distributed to unitholders.
  • The sale closed on April 22, 2021, with an effective date of April 1, 2021.

Florida Probate Law Firm Attends Florida Cemetery, Cremation & Funeral Association Annual Convention

Tuesday, July 27, 2021 - 9:00am

BOCA RATON, Fla., July 27, 2021 /PRNewswire-PRWeb/ -- Attorney Michael Bracchi, partner at the Florida Probate Law Firm PLLC , recently attended the Florida Cemetery, Cremation & Funeral Association (FCCFA) annual convention.

Key Points: 
  • BOCA RATON, Fla., July 27, 2021 /PRNewswire-PRWeb/ -- Attorney Michael Bracchi, partner at the Florida Probate Law Firm PLLC , recently attended the Florida Cemetery, Cremation & Funeral Association (FCCFA) annual convention.
  • About Florida Probate Law Firm, PLLC
    Florida Probate Law Firm, PLLC provides formal probate administration, ancillary probate administration, probate litigation, and professional executor services in all 67 counties across the state of Florida.
  • Florida Probate Law Firm, PLLC provides a modern approach to the probate process, ensuring services are provided as efficiency and stress-free as possible.
  • The Florida probate law firm offers:
    SOURCE Florida Probate Law Firm, PLLC

Affinor Announces Stock Option Grants

Monday, July 26, 2021 - 2:15pm

VANCOUVER, British Columbia, July 26, 2021 (GLOBE NEWSWIRE) -- Affinor Growers Inc. (“Affinor” or the “Company”) (CSE: AFI) (OTCQB: RSSFF) announces that it has granted an aggregate of 6,500,000 stock options (the “Options”) to directors, consultants, and an officer of the Company to purchase 6,500,000 common shares (the “Shares”) in the capital of the Company pursuant to the Company’s share option plan. The Options are exercisable at an exercise price of $0.04 per Share for a period of ten (10) years from the date of grant. The Options are subject to vesting periods over the course of the term of the Options.

Key Points: 
  • The Options are exercisable at an exercise price of $0.04 per Share for a period of ten (10) years from the date of grant.
  • The Options are subject to vesting periods over the course of the term of the Options.
  • Affinor is a publicly traded company listed on the CSE under the symbol AFI and on the OTCQB under the symbol RSSFF.
  • Affinor is focused on developing vertical farming technologies and using those technologies to grow fruits, vegetables, and cannabis in a sustainable manner.

Brooklyn Immuno Reports Inducement Grants

Friday, July 23, 2021 - 9:30pm

The unvested portion of the RSU and the Time-Based Option will terminate upon the termination of Mr. Sials employment with Brooklyn for any reason, subject to certain vesting acceleration provisions upon a qualifying termination, as described in his employment agreement with Brooklyn.

Key Points: 
  • The unvested portion of the RSU and the Time-Based Option will terminate upon the termination of Mr. Sials employment with Brooklyn for any reason, subject to certain vesting acceleration provisions upon a qualifying termination, as described in his employment agreement with Brooklyn.
  • Both of the equity awards described above were granted pursuant to the Companys 2021 Inducement Stock Incentive Plan, which was not subject to stockholder approval.
  • Brooklyn is focused on exploring the role that cytokine, gene editing, and cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases.
  • For more information about Brooklyn and its clinical programs, please visit www.BrooklynITx.com.

XAI Octagon Floating Rate & Alternative Income Term Trust Closes Public Offering of Common Shares

Friday, July 23, 2021 - 9:30pm

XAI Octagon Floating Rate & Alternative Income Term Trust (the Trust) (NYSE: XFLT), a diversified, closed-end management investment company with an investment objective to seek attractive total return with an emphasis on income generation across multiple stages of the credit cycle, has closed its previously announced underwritten public offering of 3,565,000 common shares of beneficial interest (Common Shares) at an offering price of $8.50 per Common Share.

Key Points: 
  • XAI Octagon Floating Rate & Alternative Income Term Trust (the Trust) (NYSE: XFLT), a diversified, closed-end management investment company with an investment objective to seek attractive total return with an emphasis on income generation across multiple stages of the credit cycle, has closed its previously announced underwritten public offering of 3,565,000 common shares of beneficial interest (Common Shares) at an offering price of $8.50 per Common Share.
  • The Trust intends to invest the net proceeds from the offering in accordance with its investment objective and policies.
  • XAI believes that the investing public can benefit from new vehicles to access a broad range of alternative investment strategies and managers.
  • The Trust, XAI and Octagon do not provide tax advice; consult a professional tax advisor regarding your specific tax situation.

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Thursday, July 22, 2021 - 9:05pm

The inducement stock options and RSUs have a grant date and vesting commencement date of July 16, 2021 and were granted as inducements material to the new employees entering employment with Arena in accordance with Nasdaq Listing Rule 5635(c)(4).

Key Points: 
  • The inducement stock options and RSUs have a grant date and vesting commencement date of July 16, 2021 and were granted as inducements material to the new employees entering employment with Arena in accordance with Nasdaq Listing Rule 5635(c)(4).
  • The inducement stock options and inducement RSUs are subject to the terms and conditions of Arena's Amended and Restated 2021 Long-Term Incentive Plan.
  • ARENA Pharmaceuticals is a team with a singular purpose deliver important medicines to patients.
  • Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

Northern Trust Pension Universe Data: Rising Equity Markets Lift Canadian Pension Plan Q2 Returns

Thursday, July 22, 2021 - 4:18pm

Canadian Pension Plan investment returns advanced during the second quarter, as global equities overcame inflationary fears and continued an upward trend, according to the Northern Trust Canada Universe.

Key Points: 
  • Canadian Pension Plan investment returns advanced during the second quarter, as global equities overcame inflationary fears and continued an upward trend, according to the Northern Trust Canada Universe.
  • The median Canadian Pension Plan returned 4.1% for the quarter, a reflection of positive equity markets and a healthy economic climate.
  • The Northern Trust Canada universe tracks the performance of Canadian institutional investment plans that subscribe to performance measurement services as part of Northern Trusts asset service offerings.
  • Northern Trust Corporation, Head Office: 50 South La Salle Street, Chicago, Illinois 60603 U.S.A., incorporated with limited liability in the U.S.

Isaac Wiles Law Firm Expands Estate Planning, Trust & Probate Practice Group with Attorney Jordan A. Brown

Thursday, July 22, 2021 - 4:17pm

COLUMBUS, Ohio, July 22, 2021 /PRNewswire/ -- Isaac Wiles & Burkholder LLC (Isaac Wiles), a full-service law firm in Columbus Ohio, is pleased to announce the addition of Associate, Jordan A.

Key Points: 
  • COLUMBUS, Ohio, July 22, 2021 /PRNewswire/ -- Isaac Wiles & Burkholder LLC (Isaac Wiles), a full-service law firm in Columbus Ohio, is pleased to announce the addition of Associate, Jordan A.
  • Brown, to the firm's Estate Planning, Trust & Probate practice group where he will handle matters related to elder law and estate administration and planning, with an additional focus on income and gift tax planning.
  • "We are happy to have Jordan as a new member of our growing Estate Planning group," said Isaac Wiles Partner and Chair of the firm's Estate Planning, Trust & Probate practice group, John C. Lucas.
  • Prior to joining Isaac Wiles, Jordan worked as a law clerk for several boutique law firms in Columbus, assisting attorneys with estate planning & administration, trust administration, business formation & management, real estate, intellectual property, tax, and guardianship cases.

XAI Octagon Floating Rate & Alternative Income Term Trust Prices Public Offering of Common Shares

Wednesday, July 21, 2021 - 1:47pm

The Trust agreed to sell 3,100,000 Common Shares at a price to the public of $8.50 per Common Share.

Key Points: 
  • The Trust agreed to sell 3,100,000 Common Shares at a price to the public of $8.50 per Common Share.
  • In addition, the Trust has granted the underwriters a 30-day option to purchase up to 465,000 additional Common Shares to cover over-allotments, if any.
  • The Trust intends to invest the net proceeds from the offering in accordance with its investment objective and policies.
  • The Trust, XAI and Octagon do not provide tax advice; consult a professional tax advisor regarding your specific tax situation.

XAI Octagon Floating Rate & Alternative Income Term Trust Commences Public Offering of Common Shares

Tuesday, July 20, 2021 - 9:11pm

XAI Octagon Floating Rate & Alternative Income Term Trust (the “Trust”) (NYSE: XFLT), a diversified, closed-end management investment company with an investment objective to seek attractive total return with an emphasis on income generation across multiple stages of the credit cycle, has announced that it has commenced an underwritten public offering of common shares of beneficial interest (“Common Shares”) pursuant to the Fund’s effective shelf registration statement filed with the U.S. Securities and Exchange Commission (the “SEC”). The Trust also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the Common Shares sold to cover over-allotments, if any. The final terms of the offering will depend on market and other conditions at the time of pricing, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Key Points: 
  • The Trust intends to invest the net proceeds from the offering in accordance with its investment objective and policies.
  • The offering of Common Shares may be made only by means of a prospectus.
  • XAI believes that the investing public can benefit from new vehicles to access a broad range of alternative investment strategies and managers.
  • The Trust, XAI and Octagon do not provide tax advice; consult a professional tax advisor regarding your specific tax situation.